264 related articles for article (PubMed ID: 18319313)
21. Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells.
Wendler A; Keller D; Albrecht C; Peluso JJ; Wehling M
Oncol Rep; 2011 Jan; 25(1):273-9. PubMed ID: 21109987
[TBL] [Abstract][Full Text] [Related]
22. Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression.
Peluso JJ; Liu X; Gawkowska A; Lodde V; Wu CA
Mol Cell Endocrinol; 2010 May; 320(1-2):153-61. PubMed ID: 20144686
[TBL] [Abstract][Full Text] [Related]
23. Differential responses of progesterone receptor membrane component-1 (Pgrmc1) and the classical progesterone receptor (Pgr) to 17β-estradiol and progesterone in hippocampal subregions that support synaptic remodeling and neurogenesis.
Bali N; Arimoto JM; Iwata N; Lin SW; Zhao L; Brinton RD; Morgan TE; Finch CE
Endocrinology; 2012 Feb; 153(2):759-69. PubMed ID: 22147012
[TBL] [Abstract][Full Text] [Related]
24. Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy.
Zhang N; Dai L; Qi Y; Di W; Xia P
Int J Oncol; 2013 Jun; 42(6):2053-9. PubMed ID: 23592281
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression.
Ponikwicka-Tyszko D; Chrusciel M; Stelmaszewska J; Bernaczyk P; Chrusciel P; Sztachelska M; Scheinin M; Bidzinski M; Szamatowicz J; Huhtaniemi IT; Wolczynski S; Rahman NA
EBioMedicine; 2019 Sep; 47():170-183. PubMed ID: 31466918
[TBL] [Abstract][Full Text] [Related]
26. Conditional Ablation of Progesterone Receptor Membrane Component 1 Results in Subfertility in the Female and Development of Endometrial Cysts.
McCallum ML; Pru CA; Niikura Y; Yee SP; Lydon JP; Peluso JJ; Pru JK
Endocrinology; 2016 Sep; 157(9):3309-19. PubMed ID: 27309940
[TBL] [Abstract][Full Text] [Related]
27. A high nuclear basal level of ERK2 phosphorylation contributes to the resistance of cisplatin-resistant human ovarian cancer cells.
Lee S; Yoon S; Kim DH
Gynecol Oncol; 2007 Feb; 104(2):338-44. PubMed ID: 17023032
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors.
Thomas P; Pang Y; Dong J
Endocrinology; 2014 Mar; 155(3):1107-19. PubMed ID: 24424068
[TBL] [Abstract][Full Text] [Related]
29. Changes in PGRMC1, a potential progesterone receptor, in human myometrium during pregnancy and labour at term and preterm.
Wu W; Shi SQ; Huang HJ; Balducci J; Garfield RE
Mol Hum Reprod; 2011 Apr; 17(4):233-42. PubMed ID: 21131300
[TBL] [Abstract][Full Text] [Related]
30. [Inhibition of mitochondrial Smac release by Akt in chemoresistant ovarian cancer cells].
Yang XK; Wang JD; Wang SY; Zhang YX
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):259-62. PubMed ID: 18788627
[TBL] [Abstract][Full Text] [Related]
31. Progesterone receptor membrane component 1 expression and putative function in bovine oocyte maturation, fertilization, and early embryonic development.
Luciano AM; Lodde V; Franciosi F; Ceciliani F; Peluso JJ
Reproduction; 2010 Nov; 140(5):663-72. PubMed ID: 20739377
[TBL] [Abstract][Full Text] [Related]
32. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
[TBL] [Abstract][Full Text] [Related]
33. Non-canonical progesterone signaling in granulosa cell function.
Peluso JJ; Pru JK
Reproduction; 2014 May; 147(5):R169-78. PubMed ID: 24516175
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a genomic mechanism of action for progesterone receptor membrane component-1.
Peluso JJ; DeCerbo J; Lodde V
Steroids; 2012 Aug; 77(10):1007-12. PubMed ID: 22326699
[TBL] [Abstract][Full Text] [Related]
35. Progesterone receptor membrane component 1 inhibits tumor necrosis factor alpha induction of gene expression in neural cells.
Intlekofer KA; Clements K; Woods H; Adams H; Suvorov A; Petersen SL
PLoS One; 2019; 14(4):e0215389. PubMed ID: 31026287
[TBL] [Abstract][Full Text] [Related]
36. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
37. Conditional Ablation of Progesterone Receptor Membrane Component 2 Causes Female Premature Reproductive Senescence.
Clark NC; Pru CA; Yee SP; Lydon JP; Peluso JJ; Pru JK
Endocrinology; 2017 Mar; 158(3):640-651. PubMed ID: 28005395
[TBL] [Abstract][Full Text] [Related]
38. Progesterone, Inflammatory Cytokine (TNF-α), and Oxidative Stress (H2O2) Regulate Progesterone Receptor Membrane Component 1 Expression in Fetal Membrane Cells.
Meng Y; Murtha AP; Feng L
Reprod Sci; 2016 Sep; 23(9):1168-78. PubMed ID: 26919974
[TBL] [Abstract][Full Text] [Related]
39. Expression and localization of progesterone receptor membrane component 1 and 2 and serpine mRNA binding protein 1 in the bovine corpus luteum during the estrous cycle and the first trimester of pregnancy.
Kowalik MK; Rekawiecki R; Kotwica J
Theriogenology; 2014 Nov; 82(8):1086-93. PubMed ID: 25168721
[TBL] [Abstract][Full Text] [Related]
40. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis.
Yamamoto K; Okamoto A; Isonishi S; Ochiai K; Ohtake Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):1148-54. PubMed ID: 11162647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
